Speaker illustration

Doctor Luca Testa

IRCCS San Donato Polyclinic, San Donato Milanese (Italy)

Member of:

European Association of Percutaneous Cardiovascular Interventions

Dr. Luca Testa, MD, PhD, is an Interventional Cardiologist at the IRCCS Policlinico S. Donato in Milan, Italy (https://dottorlucatesta.it/). He is Head of the Coronary Revascularization Unit and Head of the Clinical Research Unit within the Department of Cardiology. He is also Contract Professor of Cardiology for the International MD program at the “Vita e Salute” University at San Raffaele Hospital in Milan, Italy. He has published more than 200 peer reviewed articles, covering several subjects (especially in the field of transcatheter aortic valve replacement and complex coronary revascularization (https://www.ncbi.nlm.nih.gov/pubmed/?term=Testa+L+%5BAu%5D). He is also involved as Academic Editor, Section Editor and Member of the Board of several peer-reviewed journals. He is medical proctor for TAVR, CTOs, Complex PCI, Coronary Imaging, and Coronary Physiology.

Single vs. dual antiplatelet therapy in patients with severe peripheral arterial disease undergoing transcatheter aortic valve implantation: insights from the Hostile registry

Date: 15 July 2025

Journal: European Heart Journal - Cardiovascular Pharmacotherapy

Thumbnail

Stroke volume index and transvalvular flow rate trajectories in severe aortic stenosis treated with TAVR

Date: 8 February 2023

Journal: European Heart Journal - Cardiovascular Imaging

Thumbnail

Data standards for transcatheter aortic valve implantation: the European Unified Registries for Heart Care Evaluation and Randomised Trials (EuroHeart)

Date: 4 October 2022

Journal: European Heart Journal - Quality of Care and Clinical Outcomes

Thumbnail

Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves

Date: 27 June 2020

Journal: European Heart Journal

Thumbnail

Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis

Date: 6 January 2020

Journal: European Heart Journal

Thumbnail

Transcatheter aortic valve replacement—state of the art and a glimpse to the future: ‘the Tailored Approach’

Date: 29 April 2016

Journal: European Heart Journal Supplements

Thumbnail

Early decrease in coagulation activity after myocardial infarction is associated with lower risk of new ischaemic events: observations from the ESTEEM trial

Date: 3 May 2007

Journal: European Heart Journal

Thumbnail

ESC 365 is supported by